PRIMeD (Postdoc Recruitment in Immunology, Medicine, and Data sciences) is a fully funded, three-day visit that allows prospective postdoctoral fellows the opportunity to explore the breadth of research in immuno-oncology and data sciences at Fred Hutchinson Cancer Center.
The Translational Data Science and Immunotherapy Integrated Research Centers at Fred Hutchinson Cancer Center invite Ph.D. (or equivalent) students within two years of graduation or who have graduated within the past year to apply to PRIMeD (Postdoc Recruitment in Immunology, Medicine, and Data sciences) at Fred Hutchinson Cancer Center in Seattle, WA.
This fully funded, three-day visit allows prospective postdoctoral fellows the opportunity to explore the breadth of research in immuno-oncology and data sciences at Fred Hutch.
Participants will have the opportunity to share their research, learn about faculty research programs, network with Fred Hutch postdocs and faculty, and learn about the postdoctoral training environment and the vast resources available at Fred Hutch.
The core dates of the event are September 25th – 26th. However, participants are welcome to arrive early on September 24th for an optional tour of Seattle and welcome reception and will have the option to depart on September 27th.
This program is designed for students interested in pursuing a postdoctoral fellowship in immuno-oncology and/or data sciences. Students either currently in immuno-oncology, data sciences or interested in switching fields are equally encouraged to apply.
Students accepted into the program will give an oral presentation of their work, hear from Fred Hutch scientists, and have opportunities to engage in scientific discussions with Fred Hutch faculty and trainees. Following the symposium, participants can apply for open positions in labs of interest and those hired will have the opportunity to apply for postdoctoral fellowships through the IRCs.
Day 1 – September 24
Day 2 – September 25
Day 3 – September 26
Day 4 – September 27
Applications are open to students from all scientific fields interested in pursuing postdoctoral training in immuno-oncology or data sciences. Ph.D. (or equivalent) students within two years of graduation or that have graduated within the past year. Both domestic and international students (subject to visa/visa waiver requirements for non-US applicants) are encouraged to apply.
Immuno-oncology research at Fred Hutch builds on decades of pioneering work in basic immunology and transplantation with the overarching goal of discovering curative therapies for all cancers. Built from a solid foundation of translational research in solid and hematologic malignancies, our group includes strong research programs in cell therapy (TCR/CAR) and transplant immunotherapy, and is expanding in tumor microenvironment, immune checkpoint & regulation, immunogenomics, and therapeutic vaccines, among others.
Recent advancements in statistics, computational techniques and experimental technologies are transforming how we generate and analyze data. This big data has big potential. That potential can only be fully realized through collaboration between researchers with complementary skill sets, approaches, and resources. The Translational Data Science Integrated Research Center (TDS IRC) harnesses these advances and expertise to spur innovation and open new avenues for preventing and treating cancer and related diseases. The TDS IRC builds on recent data-based advances in the biomedical sciences, including technologies that are driving the generation of massive datasets, the exponential growth of publicly available data, and revolutionary approaches in statistics, machine learning and artificial intelligence that are changing data analysis.
Application deadline was July 15th.